Bernie Romanin

Chief Executive Officer and Director

Dr. Robyn A. Lindley

Chief Scientific Officer and Director

Kevin Hollingsworth

Chief Financial Officer

Richard Rendell
 
Dr. Nathan Hall
Dr. Jared Mamrot

CTO & Director

Senior Scientist

Bioinformatician

An accomplished Melbourne-based company director and CEO with 18 year’s experience in healthcare, precision medicine, life-sciences, information technology, M&A, investment, commercialisation, globalisation and compliance. ​Richard has recently been covered in Forbes magazine regarding his company Applied Precision Medicine, one of a portfolio of 4 companies he has created over a 7 year period. His success in Healthcare, Medical Device, and Digital Health sectors showcases an ability to identify and pursue emerging markets using proven adaptive business models under strong compliance and governance.  At Oracle Corporation, Richard owned several product divisions with responsibility for global strategy in sales, marketing, consulting, product development, education and support. He led technical and commercial due diligence in many Oracle acquisitions. Richard is also media trained and has worked with journalists in the United States and Australia. Richard was an advisory board founder at iSelect Pty Ltd where he returned in 2008 as CIO to deliver significant business restructuring to support new insurance markets building iSelect’s next chapter in digital strategy. iSelect listed on the ASX in June 2013 at a value of AU$300M.

LEGAL

© 2020 GMDx Genomics. All rights reserved.